Recalls
When a product is unsafe or breaks the rules, the company pulls it back and FDA classes the recall. Class I could cause serious harm or death. Class II could cause temporary harm. Class III is unlikely to hurt anyone.
5,412 recalls in the last 12 months. Newest first.
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 15 | Class I | AYCO FARMS INC Food |
Fresh Cantaloupe (Whole, Fresh), brand name Ayco, wrapped in food safe plastic bags packed in corrugated cardboard cartons; 6-12 melons per box; individual carton count per label. Keep refrigerated; store between 36 40¿F… Potential Salmonella Contamination FDA notice H-0668-2026 |
| Apr 15 | Class III | MEI YU CHENG DA TRADING INC Food |
Olive Skewers individually wrapped and packaged in clear plastic bag; 500g; INGREDIENTS: Olive, edible salt, white sugar, monosodium glutamate, licorice, cloves, food additives (citric acid, DL malic acid, saccharin, sod… Products contain banned sweetener: cyclamates. FDA notice H-0658-2026 |
| Apr 15 | Class I | Pure Vitamins and Natural Supplements, LLC Food |
Red Bull Extreme Male Enhancement Supplement, total of 15 pouches per box, Net Wt 15 G each pouch. Dosage: Consume Entire Pouch 30 Minutes before Intercourse. Produced by Red Bull Corporation. Turkey www.redbullhoney.com… FDA analysis revealed the presence of undeclared sildenafil FDA notice H-0655-2026 |
| Apr 15 | Class III | MEI YU CHENG DA TRADING INC Food |
DADI NONGFU DRIED SALT CHILLI VEGETABLE(S); Ingredients: Radish, chili, roasted sesame, prickly ash, edible salt, soybean oil, edible vinegar, white granulated sugar, spices, food additives (sodium glutamate, citric acid… Products contain banned sweetener: cyclamates. FDA notice H-0657-2026 |
| Apr 15 | Class I | Pure Vitamins and Natural Supplements, LLC Food |
Blue Bull Extreme Male Enhancement Supplement, total of 15 pouches per box, Net Wt 15 G each pouch. Dosage: Consume Entire Pouch 30 Minutes before Intercourse. Produced by Blue Bull Corporation Made In USA. UPC Code 7074… FDA analysis revealed the presence of undeclared sildenafil FDA notice H-0654-2026 |
| Apr 15 | Class II | Riverence Provisions LLC Food |
Riverence Smoked Trout Dip, net wt. 7oz. Product is perishable, refrigerated, packaged in plastic tub. Product is shipped to consignee frozen by the case (12/7oz. units per case). Retail container UPC 7 07651 30561 3. … Label declares cream cheese but does not declare milk FDA notice H-0662-2026 |
| Apr 15 | Class II | Zarlengo Italian Ice Food |
Zarlengo's Chocolate Chocolate Chip Gelato packaged in multiple sizes (6 fl oz cups, 16 fl oz cups, 32 fl oz cups, 1-gallon bucket/pail and 2-gallon bucket/pail) , Net Wt. 6 fl oz cups - clear freezer grade and round Pol… Soy Lecithin listed in ingredients statement, but Soy is not mentioned in the contains statement. FDA notice H-0650-2026 |
| Apr 15 | Class II | Zarlengo Italian Ice Food |
Zarlengo's Double Dark Chocolate Gelato packaged in 1 Gallon bucket/pail - white round food and freezer grade High-Density Polyethylene bucket/pail with tamper resistant lid. Soy Lecithin listed in ingredients statement, but Soy is not mentioned in the contains statement. FDA notice H-0652-2026 |
| Apr 15 | Class II | Connecticut Crab Company LLC Food |
Crab Cakes various sizes sold to food service May be temperature abused, which may result in growth of Clostridium botulinum FDA notice H-0656-2026 |
| Apr 15 | Class II | Cipla USA, Inc. Drug |
Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc.,… Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. FDA notice D-0422-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactu… Lack of Assurance of Sterility FDA notice D-0434-2026 |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). Superpotent and Subpotent FDA notice D-0445-2026 |
| Apr 15 | Class II | GE Healthcare Ireland Limited Drug |
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. Presence of particulate matter FDA notice D-0447-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0442-2026 |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). Superpotent and Subpotent FDA notice D-0446-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactur… Lack of Assurance of Sterility FDA notice D-0431-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC … Lack of Assurance of Sterility FDA notice D-0429-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-4… Lack of Assurance of Sterility FDA notice D-0425-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0438-2026 |
| Apr 15 | Class II | Preferred Pharmaceuticals, Inc. Drug |
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0 Lack of Assurance of Sterility FDA notice D-0443-2026 |
| Apr 15 | Class II | Viatris, Inc. Drug |
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 Failed Dissolution Specifications FDA notice D-0444-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medical Care RTG, LLC, Manufa… Lack of Assurance of Sterility FDA notice D-0433-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50. Lack of Assurance of Sterility FDA notice D-0436-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30. Lack of Assurance of Sterility FDA notice D-0437-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0439-2026 |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material FDA notice D-0474-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60. Lack of Assurance of Sterility FDA notice D-0435-2026 |
| Apr 15 | Class II | Cipla USA, Inc. Drug |
Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boul… Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. FDA notice D-0423-2026 |
| Apr 15 | Class II | GE Healthcare Ireland Limited Drug |
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91. Presence of particulate matter FDA notice D-0448-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manuf… Lack of Assurance of Sterility FDA notice D-0430-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0440-2026 |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material FDA notice D-0472-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-472-05, Unit of… Lack of Assurance of Sterility FDA notice D-0428-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 600047, Unit of Use NDC: 65219-468-05, Uni… Lack of Assurance of Sterility FDA notice D-0426-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20… Lack of Assurance of Sterility FDA notice D-0432-2026 |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material FDA notice D-0473-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 63323-626-03, Un… Lack of Assurance of Sterility FDA notice D-0424-2026 |
| Apr 15 | Class II | Fresenius Kabi USA, LLC Drug |
0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-470-05, Unit of… Lack of Assurance of Sterility FDA notice D-0427-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0441-2026 |
| Apr 15 | Class II | Beckman Coulter, Inc. Device |
MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code: 15099590720568 Intended Use- For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan pa… Due to manufacturing issue (incorrectly processing) with in vitro multidrug resistant test. FDA notice Z-1794-2026 |
| Apr 15 | Class II | Spacelabs Healthcare, Inc. Device |
Multi-parameter Command Module, Model 91496, optioned with Masimo or Nellcor Multi-parameter command module has a circuit board issue and when in Auto mode, Cardiac Output (CO) measurement may activate early, resulting in Bad Curve error with no CO measurement or Irregular Curve error with CO measurement not automatically excluded, which may result in inaccurate readings, or the need of additional readings, which may lead to delayed care and/or fluid overload. FDA notice Z-1793-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: 1. HEAD AND NECK CDS-LF, Medline SKU # CDS780138K; 2. HEART CATH PACK-L… Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1721-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: 1. SHOULDER ARTHROSCOPY PACK, Medline SKU # DYNJ30880M; 2. EXTREMITY P… Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1730-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: 1. ANGIO PACK, Medline SKU # DYNJ57032D; 2. NEURO INTERVENTIONAL RADIOL… Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1726-2026 |
| Apr 15 | Class II | Cook Incorporated Device |
COOK MEDICAL Cook Staged Extubation Set: Reference Part Number C-CAE-14.0-83-EXTU, Order Number G24073 Products from the affected device lots were labeled with expiration dates that exceed the true shelf life. FDA notice Z-1782-2026 |
| Apr 15 | Class II | Cook Incorporated Device |
COOK MEDICAL Cook¿ Spectrum¿ Central Venous Catheter Tray: Reference Part Number C-UTLMY-701J-ABRM-CUSTOM-0003, Order Number G56424; Reference Part Number C-UTLMY-701J-ABRM-CUSTOM-0018, Order Number G21053; Referenc… Products from the affected device lots were labeled with expiration dates that exceed the true shelf life. FDA notice Z-1783-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: 1. MTS RH LFT HRT KIT, Medline SKU # 60010508; 2. MTS 3V W/GUIDE, Medli… Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1724-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
NAMIC Angiographic Syringe, labeled as follows: 1. SYRINGE,20ML,CONTROL,-,PKG, Medline SKU 70075027; 2. SYRINGE,10ML,TR/FR,RA,W/RES, Medline SKU 70085007; 3. MTO,SYRINGE,10ML,TR/FG,RA,-,PKG, Medline SKU 70085107; 4. SYRI… Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1717-2026 |
| Apr 15 | Class II | Cook Incorporated Device |
COOK MEDICAL Wayne Pneumothorax Tray: Reference Part Number C-UTPTY-1400-WAYNE-112497-IMH, Order Number G56537; Reference Part Number C-UTPTY-1400-WAYNE-112497-IMH, Order Number G56537; Reference Part Number C-UTPTY… Products from the affected device lots were labeled with expiration dates that exceed the true shelf life. FDA notice Z-1792-2026 |
| Apr 15 | Class I | Medline Industries, LP Device |
Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringes), labeled as follows: GLOVE PACK 7.0 (15PK), Medline SKU # DYNJ63673D Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. FDA notice Z-1725-2026 |